
GoodRx, Novo Nordisk Offer Ozempic and Wegovy at $499/Month
GoodRx, the leading U.S. platform for prescription cost savings, has partnered with Novo Nordisk to provide all strengths of Ozempic and Wegovy pens to eligible
GoodRx, the leading U.S. platform for prescription cost savings, has partnered with Novo Nordisk to provide all strengths of Ozempic and Wegovy pens to eligible
Seasoned industry leader tapped to help pharma reimagine their go-to-market strategies and direct-to-patient models GoodRx, the leading platform for medication savings in the U.S. announced
Company working with Hy-Vee as launch partner to simplify how consumers get their medications through the GoodRx platform GoodRx, the leading platform for medication savings
Fuel up with free Health Tech Insights